| Budget Amount *help |
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2009: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2008: ¥10,140,000 (Direct Cost: ¥7,800,000、Indirect Cost: ¥2,340,000)
|
|---|
| Research Abstract |
The significance of case-finding programs to detect hepatocellular carcinoma developed during the long-term follow-up of Hepatitis C Virus-related cirrhosis are controversial issues from the viewpoints of cost-effectiveness. Diagnostic characteristics of AFP and DCP had low performances to find the early stage of hepatocellular carcinoma. The surveillance programs for hepatocellular carcinoma should estimate to prolong life expectancy at a reasonable marginal cost-effectiveness ratio, however, structural sensitivity analysis should be performed to confirm the robustness of the results.
|
